Cryo chambers offer a promising non-pharmacological adjunct therapy for individuals living with rheumatoid arthritis, a chronic autoimmune condition characterized by joint inflammation, pain, and stiffness.

By exposing the body to controlled ultra-low temperatures (typically -110°C to -150°C) for short, targeted sessions, the therapy triggers vasoconstriction that temporarily reduces blood flow to inflamed joints, alleviating swelling and acute pain.

The subsequent vasodilation then boosts circulation, delivering oxygen and nutrient-rich blood to damaged tissues to support natural repair processes.

Unlike long-term medication use that may carry side effects, cryotherapy is gentle on the body and can be tailored to individual tolerance levels, helping to improve joint mobility and reduce reliance on pain relievers.

Regular sessions have been shown to ease morning stiffness—a hallmark symptom of rheumatoid arthritis—allowing patients to engage more comfortably in daily activities and physical therapy routines.